Kdh Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -8.58%
(FY 2023)
- Profit -25.33%
(FY 2023)
- Ebitda -11.74%
(FY 2023)
- Net Worth 36.77%
(FY 2023)
- Total Assets 15.78%
(FY 2023)
About Kdh Biomedicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Upadhyay and Mamtadevi Upadhyay serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC153434
- Company No.
153434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kdh Biomedicals Private Limited offer?
Kdh Biomedicals Private Limited offers a wide range of products and services, including Laboratory Testing Equipment, Oil Tan Delta Test System, Scientific Instruments, Laboratory Instruments, Pharmaceutical Services, Molecular Biology Services.
Who are the key members and board of directors at Kdh Biomedicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamtadevi Upadhyay  | Director | 19-May-2005 | Current |
| Rajesh Upadhyay | Director | 19-May-2005 | Current |
Financial Performance of Kdh Biomedicals.
Kdh Biomedicals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.58% decrease. The company also saw a substantial fall in profitability, with a 25.33% decrease in profit. The company's net worth Soared by an impressive increase of 36.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kdh Biomedicals?
Unlock access to Kdh Biomedicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kdh Biomedicals?
Unlock and access historical data on people associated with Kdh Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kdh Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kdh Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
